Grocery delivery service Instacart will refund $60 million to settle FTC claims that it misled customers with false advertising and unlawfully enrolled them in paid subscriptions. Instacart partners ...
Maplebear (CART), more commonly known as Instacart (CART), reached a $60 million settlement with the U.S. Federal Trade Commission, resolving claims related to deceptive consumer practices. The FTC ...
Delivery company Instacart will pay $60 million in customer refunds under a settlement reached with the Federal Trade Commission over alleged deceptive practices. The FTC said Thursday that Instacart ...
A week after settling a lawsuit with rental property management company Greystar, it appears the Federal Trade Commission’s (FTC) involvement in the rental property management space is not waning. On ...
The Federal Trade Commission announced it is initiating a rulemaking process regarding deceptive fees in the rental housing industry, along with a $24M lawsuit-ending agreement with the country’s ...
A stalkerware maker who was banned from the surveillance industry after a data breach that exposed the personal information of its customers, as well as the people they were spying on, will not be ...
In November 2025, social media users (archived) began posting screenshots (archived) of an email purportedly from PayPal (archived) about money they had apparently received from an "FTC Prime ...
Journal Editorial Report: The week's best and worst from Allysia Finley, Mene Ukueberuwa and Kim Strassel. The Federal Trade Commission grabbed headlines five years ago when it sued to break up ...
Mark Zuckerberg’s Meta dodged a forced selloff of Instagram and WhatsApp after beating the Federal Trade Commission’s landmark antitrust case on Tuesday – potentially sapping the government’s momentum ...
Get started with Java streams, including how to create streams from Java collections, the mechanics of a stream pipeline, examples of functional programming with Java streams, and more. You can think ...
As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech declaring Novo's offer "superior"—even though it has already inked an ...